Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1. [provided by RefSeq, Jul 2008].
Bains, Karkling, Lubieniecka, Grigliatti, Reid, Riggs: "Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism." in: The Journal of pharmacology and experimental therapeutics, Vol. 332, Issue 3, pp. 755-63, (2010) (PubMed).
Watanabe, Sugawara, Ono, Fukuzumi, Itakura, Yamazaki, Tashiro, Osoegawa, Soeda, Nomura: "Mapping of a novel human carbonyl reductase, CBR3, and ribosomal pseudogenes to human chromosome 21q22.2." in: Genomics, Vol. 52, Issue 1, pp. 95-100, (1999) (PubMed).